New York A03116 requires health practitioners to discuss the risks of certain pain medications with patients before prescribing them, and mandates.
New York A03116 amends the public health law to mandate that health practitioners discuss the risks associated with certain pain medications with patients before issuing a prescription. Specifically, for the first opioid analgesic prescription of a calendar year exceeding a one-week supply, the prescribing physician must counsel the patient on the risks of overdose and inform them of the availability of an opioid antagonist, such as naloxone.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.